Anthem Biosciences live in four months with unified quality management system
"Veeva emerged as the best solution for us, bringing together quality processes, content, and data on a single cloud platform," stated Ravi Kalla, head, IT and process automation (OT) at Anthem Biosciences. "A complex process workflow can be designed, configured, and delivered within two weeks, demonstrating the flexibility of the Vault platform. Achieving a successful Veeva Vault Quality launch in just four weeks represents a significant leap for us toward real-time visibility, operational efficiency, and GxP compliance."
Anthem Biosciences will use Veeva Vault Quality to build a strong quality systems foundation to centrally manage and automate processes. With a unified system, Anthem Biosciences can now facilitate seamless collaboration with internal stakeholders, business partners, and suppliers. Vault Quality enables transparency to better share information with its customers, auditors, and regulatory agencies. This ensures the highest standards of quality and compliance, fostering trust and confidence across key stakeholders.
"We are excited to achieve this milestone to advance Anthem Biosciences digital quality transformation," said Varadarajan Srinivasan, general manager, Veeva Vault Quality India. "Veeva Vault Quality will provide a connected quality foundation, and support the team in their end-to-end processes for greater visibility and control."
The Vault Quality Suite includes Vault QMS, Vault QualityDocs, Vault Training, Veeva Vault Validation Management, Veeva Vault Station Manager, Veeva LearnGxP, and Veeva Vault LIMS to automate and harmonize quality processes globally. In the coming year, the company is also expected to go live with Veeva Vault QMS, completing the full adoption process.
Additional Information
For more on Veeva Vault Quality Suite, visit: veeva.com/VaultQuality
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems-apac
Hashtag: #Veeva #VeevaSystems #Healthcare #LifeSciences #Cloud #Quality
https://www.veeva.com/ap/
https://linkedin.com/company/veeva-systems-apac
The issuer is solely responsible for the content of this announcement.
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Veeva Forward-looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended October 31, 2023, which you can find here (a summary of risks which may impact our business can be found on pages 38 and 39), and in our subsequent SEC filings, which you can access at sec.gov.
More from miscw.com
China Approves AUSTEDO� For Treating Chorea Associated with Huntington’s Disease and Tardive Dyskinesia in Adults
Economic recovery drives total residential transactions to a 9-year high?Home price expected to rise by 5% in the second half of 2021, and return to 2019 peak in Q3- UK�s Specialist Domestic Energy Efficiency Event Comes to Suffolk This May, as UK and County Council Declare Climate Emergency
- Enzychem to Partner with Zydus Cadila to Manufacture COVID-19 Plasmid DNA Vaccine in Korea
